Swiss Lions 100 | 2026 edition

Bachem

Bachem is No. 87 in the Swiss Lions 100 and No. 8 in Pharma & Biotech, with a score of 39.4 out of 100. Headquarters: Bubendorf, canton of Basel-Landschaft.

Top Pharma & Biotech The full ranking
Swiss Lions score
39.4
Overall rank
87of 100

About

Maker of peptides and oligonucleotides as active ingredients for medicines, headquartered in Bubendorf, Basel-Landschaft.

How the score is made

Global scale

27.2

CHF 709m revenue.

Swiss value

60

Partly Swiss made.

Global visibility

34.9

Online attention across languages, and worldwide search interest.

Impact

35

Near-term target validated. Not a certified B Corp.

Philanthropy

0

No charitable foundation found.

Impact and philanthropy together make up the impact measure. How the ranking works.

Key figures

Revenue used in the ranking
CHF 709m12 months to June 2026, company
Revenue
CHF 709mTwelve months to 30 June 2026
Net profit
CHF 149mAttributable to shareholders
Dividends paid
CHF 67mTo all shareholders
Employees worldwide
2,725

Employees in Switzerland and dividends paid to Swiss shareholders are not published consistently, so they are not shown.

Profile

Headquarters
BubendorfCanton of Basel-Landschaft
Language region
German-speaking
Ownership
Listed
Main customers
Businesses (B2B)
Chief executive
Anne-Kathrin StollerSince 2026. Source
Founded
1971

Nearby in the Swiss Lions 100

Also in Pharma & Biotech

See all 8 brands in Pharma & Biotech.

Sources

  • Revenue used in the ranking: stockanalysis.com BANB (12 months to June 2026).
  • Revenue, net profit, dividends and employees: stockanalysis.com, from company filings.
  • Climate target: Science Based Targets initiative dashboard, October 2026. Foundations: Swiss commercial register. B Corp: B Lab directory.

Something out of date?

If a figure is wrong, or Bachem can publish figures for the next edition, tell us. Corrections are recorded with their source.

Send a correction How the ranking works
Scroll to Top